VOYAGER THERAPEUTICS, INC. (VYGR) Share Price 15.00-17.00 Shares Offered 4,687,500 Offer Amount $91,640,625.00 Total Expenses $2,050,000.00 They are a clinical-stage gene therapy company focused on developing life-changing treatments for patients suffering from severe diseases of the central nervous system, or CNS. We focus on … More IPO’S


                  OASMIA PHARMACEUTICAL AB (OASM) Share Price $4.06 Shares Offered 2,339,200 Offer Amount $9,497,152.00 Total Expenses $1,513,292.98 They are a pharmaceutical company focused on innovative treatments within human and animal oncology. Our product and product candidates utilize a proprietary, nanoparticle formulation technology that is designed to facilitate … More IPO’S


           DIMENSION THERAPEUTICS, INC. (DMTX) Share Price $13.00 Shares Offered 5,500,000 Offer Amount $71,500,000.00 Total Expenses $3,050,000.00 Shares Outstanding 24,879,574 They are a leading gene therapy platform company focused on discovering and developing new therapeutic products for people living with rare diseases associated with the liver and caused by genetic mutations. … More IPO’S


The AUDCAD is working on its fourth month of trading inside of a 340 pip range. As seen above, price has recently traded off of resistance near .9740, which coincides with its May 2015 high. Previous moves from this point of resistance, have pointed price towards support near .9400. If range bound conditions continue, traders … More AUD/CAD 4H

New Zealand Dollar Fell as Labor Data Led to RBNZ Rate Cut Bets

The Kiwi Dollar dropped 0.6 percent against its US namesake as a set of disappointing labor statistics from New Zealand crossed the wires. Unemployment in the third quarter met the consensus forecast at 6 percent – 0.1 percentage points higher than the previous reading. This marks the highest level since June of 2014. The quarter-over-quarter … More New Zealand Dollar Fell as Labor Data Led to RBNZ Rate Cut Bets